Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer (TEP-FES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03442504
Recruitment Status : Recruiting
First Posted : February 22, 2018
Last Update Posted : May 15, 2019
Sponsor:
Information provided by (Responsible Party):
Institut Cancerologie de l'Ouest

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : March 2021